MA32080B1 - Vaccin comprenant un extrait de protéine ribosomale (rpe) et facultativement un adjuvant promouvant la réponse th1 - Google Patents
Vaccin comprenant un extrait de protéine ribosomale (rpe) et facultativement un adjuvant promouvant la réponse th1Info
- Publication number
- MA32080B1 MA32080B1 MA33087A MA33087A MA32080B1 MA 32080 B1 MA32080 B1 MA 32080B1 MA 33087 A MA33087 A MA 33087A MA 33087 A MA33087 A MA 33087A MA 32080 B1 MA32080 B1 MA 32080B1
- Authority
- MA
- Morocco
- Prior art keywords
- rpe
- optionally
- response
- vaccine
- ribosomal protein
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/002—Protozoa antigens
- A61K39/008—Leishmania antigens
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P33/00—Antiparasitic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P33/00—Antiparasitic agents
- A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P33/00—Antiparasitic agents
- A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
- A61P33/06—Antimalarials
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/04—Immunostimulants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
- A61K2039/52—Bacterial cells; Fungal cells; Protozoal cells
- A61K2039/521—Bacterial cells; Fungal cells; Protozoal cells inactivated (killed)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
- A61K2039/55511—Organic adjuvants
- A61K2039/55561—CpG containing adjuvants; Oligonucleotide containing adjuvants
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Landscapes
- Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Tropical Medicine & Parasitology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Immunology (AREA)
- Organic Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Microbiology (AREA)
- Mycology (AREA)
- Epidemiology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Abstract
La présente invention concerne une composition comprenant un rpe et facultativement un adjuvant promouvant la réponse th1 pour la préparation d'un médicament destiné au traitement ou à la prévention d'une maladie parasitaire, ainsi que son utilisation.
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US2192808P | 2008-01-18 | 2008-01-18 | |
EP08100634 | 2008-01-18 | ||
PCT/EP2009/050334 WO2009090175A1 (fr) | 2008-01-18 | 2009-01-14 | Vaccin comprenant un extrait de protéine ribosomale (rpe) et facultativement un adjuvant promouvant la réponse th1 |
Publications (1)
Publication Number | Publication Date |
---|---|
MA32080B1 true MA32080B1 (fr) | 2011-02-01 |
Family
ID=39471089
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
MA33087A MA32080B1 (fr) | 2008-01-18 | 2010-08-13 | Vaccin comprenant un extrait de protéine ribosomale (rpe) et facultativement un adjuvant promouvant la réponse th1 |
Country Status (20)
Country | Link |
---|---|
US (1) | US20110020405A1 (fr) |
EP (2) | EP2570427A1 (fr) |
JP (2) | JP2011509968A (fr) |
CN (1) | CN101977930B (fr) |
AP (1) | AP3007A (fr) |
AU (1) | AU2009204849B2 (fr) |
BR (1) | BRPI0906787A2 (fr) |
CA (1) | CA2712475A1 (fr) |
CO (1) | CO6280495A2 (fr) |
DK (1) | DK2231700T3 (fr) |
ES (1) | ES2486365T3 (fr) |
HK (1) | HK1150291A1 (fr) |
HR (1) | HRP20140447T1 (fr) |
MA (1) | MA32080B1 (fr) |
MX (1) | MX2010007831A (fr) |
PL (1) | PL2231700T3 (fr) |
PT (1) | PT2231700E (fr) |
RU (1) | RU2521499C2 (fr) |
WO (1) | WO2009090175A1 (fr) |
ZA (1) | ZA201005143B (fr) |
Families Citing this family (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
SA110310855B1 (ar) | 2009-11-13 | 2014-09-16 | Laboratories Leti S L Unipersonal | استخدام مصدر l3 و/ أو l5 كلقاح أو كوسيلة تشخيصية لمرض طفيلي |
WO2012062861A1 (fr) | 2010-11-10 | 2012-05-18 | Laboratorios Leti, S.L. | Nouvel adjuvant |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6500437B1 (en) * | 1995-09-22 | 2002-12-31 | Corixa Corporation | Leishmania antigens for use in the therapy and diagnosis of leishmaniasis |
ATE429498T1 (de) * | 1998-12-23 | 2009-05-15 | Leti Sl Lab | Chimärisches gen, dass für die antigenischen determinanten von vier proteinen aus l. infantum kodiert |
ES2169995B1 (es) * | 2000-04-17 | 2003-12-01 | Leti Lab | Composicion a base de la proteina lip2a y su uso en la preparacion de un medicamento para suscitar una respuesta inmune contra un antigeno. |
US20030072714A1 (en) * | 2001-10-12 | 2003-04-17 | Magill Alan J. | Microfluidized leishmania lysate and methods of making and using thereof |
-
2009
- 2009-01-14 CA CA2712475A patent/CA2712475A1/fr not_active Abandoned
- 2009-01-14 DK DK09701571.3T patent/DK2231700T3/da active
- 2009-01-14 CN CN200980109592.8A patent/CN101977930B/zh not_active Expired - Fee Related
- 2009-01-14 MX MX2010007831A patent/MX2010007831A/es active IP Right Grant
- 2009-01-14 EP EP20120196741 patent/EP2570427A1/fr not_active Withdrawn
- 2009-01-14 EP EP09701571.3A patent/EP2231700B1/fr not_active Not-in-force
- 2009-01-14 AU AU2009204849A patent/AU2009204849B2/en not_active Ceased
- 2009-01-14 ES ES09701571.3T patent/ES2486365T3/es active Active
- 2009-01-14 PT PT97015713T patent/PT2231700E/pt unknown
- 2009-01-14 RU RU2010134427/10A patent/RU2521499C2/ru not_active IP Right Cessation
- 2009-01-14 PL PL09701571T patent/PL2231700T3/pl unknown
- 2009-01-14 AP AP2010005333A patent/AP3007A/xx active
- 2009-01-14 JP JP2010542611A patent/JP2011509968A/ja active Pending
- 2009-01-14 US US12/863,562 patent/US20110020405A1/en not_active Abandoned
- 2009-01-14 WO PCT/EP2009/050334 patent/WO2009090175A1/fr active Application Filing
- 2009-01-14 BR BRPI0906787-6A patent/BRPI0906787A2/pt not_active IP Right Cessation
-
2010
- 2010-07-16 CO CO10087106A patent/CO6280495A2/es not_active Application Discontinuation
- 2010-07-19 ZA ZA2010/05143A patent/ZA201005143B/en unknown
- 2010-08-13 MA MA33087A patent/MA32080B1/fr unknown
-
2011
- 2011-04-27 HK HK11104241.6A patent/HK1150291A1/xx not_active IP Right Cessation
-
2014
- 2014-05-19 HR HRP20140447AT patent/HRP20140447T1/hr unknown
-
2015
- 2015-04-30 JP JP2015093123A patent/JP2015180638A/ja active Pending
Also Published As
Publication number | Publication date |
---|---|
HRP20140447T1 (hr) | 2014-07-04 |
CO6280495A2 (es) | 2011-05-20 |
US20110020405A1 (en) | 2011-01-27 |
EP2231700A1 (fr) | 2010-09-29 |
AP3007A (en) | 2014-10-31 |
EP2570427A1 (fr) | 2013-03-20 |
ZA201005143B (en) | 2011-12-28 |
BRPI0906787A2 (pt) | 2015-08-18 |
CN101977930A (zh) | 2011-02-16 |
AU2009204849B2 (en) | 2013-10-03 |
AU2009204849A1 (en) | 2009-07-23 |
PT2231700E (pt) | 2014-07-31 |
ES2486365T3 (es) | 2014-08-18 |
RU2010134427A (ru) | 2012-02-27 |
CA2712475A1 (fr) | 2009-07-23 |
HK1150291A1 (en) | 2011-11-18 |
WO2009090175A1 (fr) | 2009-07-23 |
MX2010007831A (es) | 2011-06-20 |
AP2010005333A0 (en) | 2010-08-31 |
EP2231700B1 (fr) | 2014-05-07 |
DK2231700T3 (da) | 2014-07-14 |
JP2011509968A (ja) | 2011-03-31 |
RU2521499C2 (ru) | 2014-06-27 |
JP2015180638A (ja) | 2015-10-15 |
PL2231700T3 (pl) | 2014-09-30 |
CN101977930B (zh) | 2014-12-17 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
MA29406B1 (fr) | Vaccin toxoide alpha de c. perfringens | |
MA28149A1 (fr) | Compositions de vaccin comprenant une interleukine 18 et un systeme adjuvant de type saponine | |
MA29714B1 (fr) | Vaccin | |
MA30298B1 (fr) | Composition | |
MA30866B1 (fr) | Vaccin | |
MA47313A (fr) | Formulations sous-cutanées d'anticorps her2 | |
WO2008014979A3 (fr) | Acide nucléique de formule (i): gixmgn, ou(ii): cixmcn, en particulier en tant qu'agent/adjuvant immunostimulant | |
MA33449B1 (fr) | Antigènes recombinants du vrs | |
BRPI0409459A (pt) | novas composições imunogênicas para a prevenção e tratamento de doença meningocócica | |
BR0212999A (pt) | novas composições imunogênicas para a prevenção e tratamento de doença meningocócica | |
MX2009006760A (es) | Composiciones inmunogenicas novedosas para la prevencion y tratamiento de enfermedades meningococicas. | |
BRPI0510430A (pt) | composições e métodos para vacinação mucosal | |
EA200900024A1 (ru) | Противогриппозная вакцина | |
MA34019B1 (fr) | Aryltriazolone liée à un bis-aryle et son utilisation | |
MA34120B1 (fr) | Composition pharmaceutique | |
TN2011000353A1 (fr) | Derives de thiadiazoles et d'oxadiazoles, leur preparation et leur application en therapeutique | |
UA99094C2 (ru) | Способ лечения пациента с системной красной волчанкой | |
WO2006060710A3 (fr) | Preparations de vaccins destinees a une administration intradermique, contenant des adjuvants et des agents antigeniques | |
EA200701113A1 (ru) | Макролиды | |
UA100507C2 (ru) | Предупреждение и лечение субклинической формы болезней, вызываемых цирковирусом свиней (pcvd) | |
TW200633719A (en) | Glycoconjugate vaccines containing peptidoglycan | |
MA35513B1 (fr) | Compositions pharmaceutiques comprenant 40 - o - ( 2 - hydroxy) éthyl - rapamycine | |
MA33419B1 (fr) | Composés et compositions pour le traitement de maladies parasitaires | |
EA202091690A1 (ru) | Иммуногенная композиция, содержащая стафилококковые антигены | |
GB2453491A (en) | Immunogenic proteins of burkholderia pseudomallei and uses thereof |